As of 2026-08-21, Scholar Rock Holding Corporation Common Stock (SRRK) has a 3-month relative strength percentile of 79 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.5%, relative volume 1.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SRRK is in a stage 2 uptrend, week 3. Currently in a 31-day base; basing ADR 4.5% (broad 4.4%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 9.5% / 21.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
SRRK is held by 24 ETFs as of May 2026. Top owner: VTWO at 0.13% weight, $22M notional. Top 3 carry $51M.
Held by 58 ETFs · $547M across latest filings · largest weight 3.67% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.13% | $22M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.09% | $20M | — |
| VHTVanguard Health Care ETF | 0.05% | $9M | — |
| VTWG | 0.22% | $4M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $2M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| ONEQ | 0.01% | $1M | — |
| ESML | 0.05% | $1M | −0.02 pp |
| ESGV | 0.01% | $964K | — |
| HRTS | 0.92% | $476K | +0.13 pp |
| VTHRVanguard Russell 3000 ETF | 0.01% | $364K | — |
Showing 10 of 24 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK Jan avg: 0.50% median: -2.96% win: 50% σ: 24.79% n: 4 2022-04-12 → 2026-07-31 | SRRK Feb avg: -5.50% median: -2.01% win: 25% σ: 16.97% n: 4 2022-04-12 → 2026-07-31 | SRRK Mar avg: 0.42% median: 2.14% win: 50% σ: 15.00% n: 4 2022-04-12 → 2026-07-31 | SRRK Apr avg: -15.42% median: -17.40% win: 20% σ: 15.05% n: 5 2022-04-12 → 2026-07-31 | SRRK May avg: -16.03% median: -11.85% win: 20% σ: 16.64% n: 5 2022-04-12 → 2026-07-31 | SRRK Jun avg: 12.26% median: 11.56% win: 80% σ: 15.49% n: 5 2022-04-12 → 2026-07-31 | SRRK Jul avg: 3.74% median: 4.60% win: 60% σ: 14.88% n: 5 2022-04-12 → 2026-07-31 | SRRK Aug avg: 0.04% median: -4.73% win: 50% σ: 15.87% n: 4 2022-04-12 → 2026-07-31 (current) | SRRK Sep avg: -0.78% median: -0.14% win: 50% σ: 16.91% n: 4 2022-04-12 → 2026-07-31 | SRRK Oct avg: 85.27% median: 53.23% win: 75% σ: 118.84% n: 4 2022-04-12 → 2026-07-31 | SRRK Nov avg: 18.93% median: 23.68% win: 75% σ: 31.80% n: 4 2022-04-12 → 2026-07-31 | SRRK Dec avg: 18.52% median: 12.40% win: 75% σ: 21.61% n: 4 2022-04-12 → 2026-07-31 |